Company intelligence / Profile preview

Gel-Del Technologies

St. Paul, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Gel-Del Technologies produces protein-based biomaterials for medical devices and drug delivery, focusing on biomatrix materials that mimic natural tissue scaffolds. Its thermoplastic biomaterial technologies are applied in tissue engineering, wound healing, and cardiovascular devices. The company is in a pre-clinical or early development stage, with no publicly reported clinical results.

Therapeutic areas: CardiovascularOtherDermatology
Modalities: Protein-based biomatrixHydrogel-based drug delivery therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Gel-Del Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gel-Del Technologies.

Explore the full profile